Viewing Study NCT01002703


Ignite Creation Date: 2025-12-24 @ 7:43 PM
Ignite Modification Date: 2026-05-13 @ 7:45 AM
Study NCT ID: NCT01002703
Status: UNKNOWN
Last Update Posted: 2011-08-12
First Post: 2009-10-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Treatment With Lenalidomide, Bendamustine and Prednisone (RBP) in Patients With Relapsed or Refractory Multiple Myeloma
Sponsor: University of Leipzig
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lenalidomide View
None Bendamustine View
None Multiple Myeloma View
None Myeloma View
None Revlimid View
None Phase I/II View
None refractory Myeloma View
None relapsed Myeloma View